NO20053720L - Antimikrobielt preparat for lokal anvendelse pa slimhinnemembraner og hud - Google Patents
Antimikrobielt preparat for lokal anvendelse pa slimhinnemembraner og hudInfo
- Publication number
- NO20053720L NO20053720L NO20053720A NO20053720A NO20053720L NO 20053720 L NO20053720 L NO 20053720L NO 20053720 A NO20053720 A NO 20053720A NO 20053720 A NO20053720 A NO 20053720A NO 20053720 L NO20053720 L NO 20053720L
- Authority
- NO
- Norway
- Prior art keywords
- composition
- skin
- mucous membranes
- local application
- preparation
- Prior art date
Links
- 230000000845 anti-microbial effect Effects 0.000 title abstract 4
- 210000004400 mucous membrane Anatomy 0.000 title 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 2
- 102000016943 Muramidase Human genes 0.000 abstract 2
- 108010014251 Muramidase Proteins 0.000 abstract 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract 2
- 102000018358 immunoglobulin Human genes 0.000 abstract 2
- 229940072221 immunoglobulins Drugs 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 229960000274 lysozyme Drugs 0.000 abstract 2
- 235000010335 lysozyme Nutrition 0.000 abstract 2
- 239000004325 lysozyme Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 241000192125 Firmicutes Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 150000002772 monosaccharides Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2462—Lysozyme (3.2.1.17)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SAMMENDRAG Oppfinnelsen angår et antimikrobielt preparat for lokal anvendelse på slimhinnemembraner og hud. Det antimikrobielle preparatet omfatter et system av lysozym og glykosylerte immunoglobuliner. De glykosylerte immunoglobulinene har affinitet mot gramnegative og grampositive bakterier og virus. Videre angår oppfinnelsen fremgangsmåten for å fremstille nevnte preparat så vel som anvendelse av preparatet for behandlingen og/eller forebyggingen av infeksjoner. Den foreliggende oppfinnelse angår videre et antimikrobielt preparat omfattende lysozym konjugert til et monosakkarid. Fremgangsmåten for å fremstille nevnte preparat så vel som anvendelsen av preparatet for behandlingen og/eller forebyggingen av infeksjoner er også beskrevet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK200301858A DK200301858A (da) | 2002-01-16 | 2003-01-16 | Antimikrobielt præparat til lokal anvendelse på hud og slimhinder |
PCT/DK2003/000940 WO2004060397A1 (en) | 2003-01-02 | 2003-12-30 | Antimicrobial composition for local use on mucosal membranes and skin |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20053720L true NO20053720L (no) | 2005-08-02 |
NO335291B1 NO335291B1 (no) | 2014-11-03 |
Family
ID=32695534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053720A NO335291B1 (no) | 2003-01-16 | 2005-08-02 | Antimikrobielt preparat for lokal anvendelse på slimhinnemembraner og hud |
Country Status (10)
Country | Link |
---|---|
US (1) | US20060233781A1 (no) |
EP (1) | EP1587539B1 (no) |
AT (1) | ATE476199T1 (no) |
AU (1) | AU2003287936A1 (no) |
CA (1) | CA2551760A1 (no) |
DE (1) | DE60333679D1 (no) |
DK (1) | DK1587539T3 (no) |
NO (1) | NO335291B1 (no) |
PL (1) | PL378216A1 (no) |
WO (1) | WO2004060397A1 (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX340019B (es) | 2010-11-23 | 2016-06-22 | Pantheryx Inc | Composiciones y metodos para el tratamiento en aplicaciones clinicas de amplio espectro, no diferenciadas o combinadas. |
US9913903B2 (en) * | 2015-08-06 | 2018-03-13 | Grifols Worldwide Operations Limited | Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM |
EP3479699A1 (en) * | 2017-11-03 | 2019-05-08 | Agriculture and Food Development Authority (TEAGASC) | A composition and uses thereof |
CN117717612A (zh) * | 2023-12-19 | 2024-03-19 | 中山自然说生物科技有限公司 | 一种私密护理组合物及其制备方法和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3426903A1 (de) * | 1984-07-20 | 1986-01-23 | Biotest Pharma GmbH, 6000 Frankfurt | Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten |
FR2573627B1 (fr) | 1984-11-29 | 1986-12-26 | Entremont Sa | Procede pour la fabrication de produits laitiers au moyen d'anticorps |
GB8906796D0 (en) | 1989-03-23 | 1989-05-10 | Medical Research Interntional | Method of enhancing neutralising antibody activity in human or animal sera or in other body secretions |
RU2070889C1 (ru) * | 1993-03-30 | 1996-12-27 | Институт пищевых веществ РАН | Лизоцимполисахаридный конъюгат |
AU6880798A (en) | 1998-04-02 | 1999-10-25 | Procter & Gamble Company, The | Multiple zone member |
JP2000270858A (ja) * | 1999-03-26 | 2000-10-03 | Taiyo Kagaku Co Ltd | リゾチーム糖複合体 |
EP1068871A1 (en) * | 1999-07-07 | 2001-01-17 | Jean-Paul Perraudin | Novel methods and medicament for treating infections diseases involving microbial biofilms |
-
2003
- 2003-12-30 AT AT03779776T patent/ATE476199T1/de not_active IP Right Cessation
- 2003-12-30 PL PL378216A patent/PL378216A1/pl not_active Application Discontinuation
- 2003-12-30 EP EP03779776A patent/EP1587539B1/en not_active Expired - Lifetime
- 2003-12-30 DK DK03779776.8T patent/DK1587539T3/da active
- 2003-12-30 AU AU2003287936A patent/AU2003287936A1/en not_active Abandoned
- 2003-12-30 WO PCT/DK2003/000940 patent/WO2004060397A1/en not_active Application Discontinuation
- 2003-12-30 DE DE60333679T patent/DE60333679D1/de not_active Expired - Lifetime
- 2003-12-30 US US10/541,068 patent/US20060233781A1/en not_active Abandoned
- 2003-12-30 CA CA002551760A patent/CA2551760A1/en not_active Abandoned
-
2005
- 2005-08-02 NO NO20053720A patent/NO335291B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1587539B1 (en) | 2010-08-04 |
DK1587539T3 (da) | 2010-11-08 |
EP1587539A1 (en) | 2005-10-26 |
NO335291B1 (no) | 2014-11-03 |
WO2004060397A1 (en) | 2004-07-22 |
US20060233781A1 (en) | 2006-10-19 |
PL378216A1 (pl) | 2006-03-20 |
CA2551760A1 (en) | 2004-07-22 |
ATE476199T1 (de) | 2010-08-15 |
DE60333679D1 (de) | 2010-09-16 |
AU2003287936A1 (en) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999052515A3 (de) | Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen | |
AU2003282358A1 (en) | Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil | |
WO2002007742A3 (en) | Bacteriophage having multiple host range | |
WO2003077828A3 (en) | Novel florfenicol-type antibiotics | |
EP2279662A3 (en) | 5,7,4'-trihydroxy-3',5'-dimethoxyflavone as an antibacterial agent | |
WO2003000200A3 (en) | β-2'-OR 3'-HALONUCLEOSIDES | |
BRPI0413234A (pt) | derivados de imidazola bicìclica contra flaviviridae | |
BR0211482B1 (pt) | compostos fungicidas, seus processos de preparaÇço e suas aplicaÇÕes, composiÇço e processo para combater microorganismos indesejados e processo de preparaÇço da referida composiÇço. | |
WO2006013441A3 (en) | Use of probiotic bacteria for the preparation of topical compositions for skin protection | |
AU2002244710A1 (en) | Chlamydia vaccine composition | |
WO2003099217A3 (en) | Methods of treating bacterial infections and diseases associated therewith | |
WO2007053176A3 (en) | Method of protecting against staphylococcal infection | |
DE69835536D1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
NO20053720L (no) | Antimikrobielt preparat for lokal anvendelse pa slimhinnemembraner og hud | |
WO2004098536A3 (en) | Anti-viral activity of cathelicidin peptides | |
CL2004000710A1 (es) | Composicion antimicrobiana y antiparasitaria formada por un antibiotico derivado del cloranfenicol o tianfenicol, un endectocida y por lo menos un vehiculo aceptable, y su uso para tratar enfermedades respiratorias y parasitarias de los bovinos. | |
BR9712141A (pt) | Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas. | |
EP1670490A4 (en) | METHOD FOR INHIBITING BACTERIAL COLONIZATION | |
AU2002364964A1 (en) | Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections | |
WO2008105826A3 (en) | Compositions compromising lysostaphin variants and methods of using the same | |
AU2002365083A1 (en) | Composition and method to treat viral bacterial and parasitic infections and infestations | |
ATE364389T1 (de) | Verfahren zur herstellung von extrakten aus pelargonium sidoides und/oder pelargonium reniforme | |
WO2007050978A3 (en) | Methods for the elimination of pathogens and other particulate agents | |
WO2003024996A3 (de) | Antibakterielle makrozyklen | |
DE60137459D1 (de) | Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: ACAPO AS, POSTBOKS 1880 NORDNES, 5817 BERGEN, NORG |
|
MK1K | Patent expired |